Quick Takeaways
- Woodline Partners LP filed SCHEDULE 13G/A for Tenaya Therapeutics, Inc. Common Stock, par value $0.0001 per share (TNYA).
- Disclosed ownership: 5%.
- Date of event: 30 Jun 2025.
Woodline Partners LP - 30 Jun 2025 SCHEDULE 13G/A Report for Tenaya Therapeutics, Inc. Common Stock, par value $0.0001 per share (TNYA)
- Filing Manager
- Woodline Partners LP
- Reporting Manager
- Woodline Partners LP
- Symbol
- TNYA
- Shares outstanding
- 180,360,721 shares
- Disclosed Ownership
- 9,000,000 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 11:59:25 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Woodline Partners LP disclosed 5% ownership in Tenaya Therapeutics, Inc. Common Stock, par value $0.0001 per share (TNYA) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 14 Aug 2025, 11:59.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Woodline Partners LP | 5% | 9,000,000 | 9,000,000 | 0 | /s/ Erin Mullen | Erin Mullen, General Counsel & Chief Compliance Officer |